Moreover, the level of body weight and the severity of diabetes, which were both associated with risk for pancreatitis and pancreatic cancer, were not well matched between the GLP-1 receptor agonist and control groups [27]. This evidence concerns the gene GLP1R and familial pancreatic carcinoma.